The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Volume 16 - 2025 |
doi: 10.3389/fimmu.2025.1556844
This article is part of the Research Topic Community Series in Advances in Pathogenesis and Therapies of Gout: Volume II View all 10 articles
Editorial: Advances in Diagnosis and Interventions of Gout
Provisionally accepted- 1 Jiangxi Provincial People's Hospital, Nanchang, China
- 2 Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China
- 3 Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, United States
- 4 Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
- 5 Department of Rheumatology and Clinical Immunology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province, China
The pathogenesis of gout involves the formation and deposition of monosodium urate (MSU) crystals in tissues due to elevated serum uric acid. MSU is recognized and phagocytic by macrophages, and subsequently activates the inflammasome NOD-like receptor thermal protein domain associated protein 3 (NLRP3), produces interleukin (IL)-1β and promotes the release of other pro-inflammatory factors and the aggregation of neutrophils, thereby triggering local or even systemic inflammatory responses (2). With the improvement of living standards and the increase in purine intake, the incidence of hyperuricemia and gout is increasing annually (3). It is worth noting that hyperuricemia has become an independent risk factor for various systemic diseases, especially cardiovascular diseases and chronic kidney diseases (4,5). To further identify new strategies for the prevention and improvement of hyperuricemia as well as gout, this Research Topic exhibits a number of original research articles on the topic of advances in diagnosis, genetic involvement, pathogenesis, and comorbidities of hyperuricemia and gout.In this Research Topic, He et al. explored the relationship between the Oxidative Balance Score (OBS, composed of scores for 20 dietary and lifestyle factors) and hyperuricemia/gout. Among adult participants in the National Health and Nutrition Examination Survey (NHANES) spanning from 2009 to 2018, higher OBS was found to be associated with a decreased risk of developing hyperuricemia/gout, underscoring its potential in the prevention and management of these conditions. Life's Essential 8 (LE8) is a comprehensive measure of cardiovascular health promoted by the American Heart Association, and Wang et al. suggested that higher LE8 scores are robustly associated with lower odds of hyperuricemia.Recent reports have suggested that the intestine may play a crucial role in the excretion of uric acid outside the kidneys (6). Yang et al. performed a large Taiwanese population study to examine the risk factors for self-reported peptic ulcer disease (PUD), and found that hyperuricemia was associated with low prevalence of self-reported PUD in males, but not in females. Gouty nephropathy (GN) is a renal condition caused by precipitation of MSU in the kidney tubules (7). Li et al.introduced a new approach for the induction of GN by intrarenal injection of MSU, which may potentially serve as an experimental groundwork for future studies on the pathogenesis and prevention strategies of GN. Uric acid excretion in the intestine and kidney is closely related to the polymorphism of ABCG2 gene. Many common variants associated with gout have been reported, e.g., rs22331142 in ABCG2 in a Taiwanese population (8). Nevertheless, Tseng et al. identified the rare variants rs559954634, rs186763678, and 13-85340782-G-A for the first time to be associated with gout in Taiwanese male, and the mechanism of these rare variants is worthy of further study.
Keywords: Gout, Inflammasome, Hyperuricemia, Monosodium urate (MSU) crystal, cardiocascular disease
Received: 07 Jan 2025; Accepted: 13 Jan 2025.
Copyright: © 2025 Duan, Zhong, Yang, Zhu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Lihua Duan, Jiangxi Provincial People's Hospital, Nanchang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.